IN SILICO SCREENING BY MOLECULAR DOCKING OF HETEROCYCLIC COMPOUNDS WITH FURAN OR INDOLE NUCLEUS FROM DATABASE FOR ANTICANCER ACTIVITY AND VALIDATION OF THE METHOD BY REDOCKING

THOMAS KURIAN

doi:10.22159/ijpps.2024v16i4.50478

Authors

THOMAS KURIAN College of Pharmacy Govt, Medical College, Alappuzha Kerala-688005, India

DOI:

https://doi.org/10.22159/ijpps.2024v16i4.50478

Keywords:

Docking, Pyrex, Indole, Furan, Cancer, Redocking

Abstract

Objective: This study aims to perform in silico screening of nine heterocyclic ligands containing furan or indole with oxygen in their structure selected from the compound database based on a literature review for predicting their anticancer activity on tyrosine kinase receptor receptors.

Methods: The receptor is complex with the ligand Gliteritinib and was downloaded from the protein database. The ligands used for this study were 5-fluoro-1H-indole-2-carboxylic acid,2(5H)-Furanone Furfuryl pentanoate, Furan-2,5-dicarbaldehyde, 2,5-Furandicarboxylic acid, Furan-2-yl(1H-indol-3-yl) methanone, Tert-butyl 3-formyl-1H-indole-1-carboxylate,7-Amino-5-fluoroindolin-2-one,7H-Furo[3,2-g]chromen-7-one. Pyrex molecular docking software was used to perform the analysis. The study was validated using a re-docking technique using the ligand Gliteritinib.

Results: A good docking score of (-7.8) was obtained for tert-butyl 3-formyl-1H-indole-1-carboxylate, leading to promising activity prediction. Furan-2-yl(1H-indol-3-yl) methadone and 7H-Furo[3,2-g]chromen-7-one also scored well with (-7.5) and (-7.3) respectively. The redocking process resulted in a score of (-9.2).

Conclusion: Values are comparable to the root primary square value, showing the reproducibility of this method. The finding gives insight into Insilco docking for anticancer activity and further exploration of phytochemicals for Insilco screening.

Downloads

Download data is not yet available.

References

Kassem AF, Nassar IF, Abdel-Aal MT, Awad HM, El-Sayed WA. Synthesis and anticancer activity of new ((furan-2-yl)-1,3,4-thiadiazolyl)-1,3,4-oxadiazole acyclic sugar derivatives. Chem Pharm Bull. 2019;67(8):888-95. doi: 10.1248/cpb.c19-00280.

Kitel R, Byczek Wyrostek A, Hopko K, Kasprzycka A, Walczak K. Effect of selected silyl groups on the anticancer activity of 3,4-dibromo-5-hydroxy-furan-2(5H)-one derivatives. Pharmaceuticals (Basel). 2021;14(11):1079. doi: 10.3390/ph14111079, PMID 34832861.

Sachdeva H, Khaturia S, Saquib M, Khatik N, Khandelwal AR, Meena R. Oxygen- and sulphur-containing heterocyclic compounds as potential anticancer agents. Appl Biochem Biotechnol. 2022;194(12):6438-67. doi: 10.1007/s12010-022-04099-w, PMID 35900713.

Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018 Dec;17(1):58. doi: 10.1186/s12943-018-0782-4, PMID 29455648.

National Center for Biotechnology Information (NCBI). Bethesda: National Library of Medicine (US). National Center for Biotechnology Information; 1988. Available from: https://www.ncbi.nlm.nih.gov. [Last accessed on 29 Feb 2024]

Karpakavalli M, Kumar PR, Sanglimuthu A, Kumar EP. Docking, synthesis, characterization, and anticancer activity of 4-(4'-hydroxy, 3'-methoxy) phenyl, but-2-one-3-ene, a curcumin analog precursor. Int J Curr Pharm Rev Res. 2016;8(4):1-5.

Morris GM, Lim-Wilby M. Molecular docking. In: Molecular modeling of proteins; 2008. p. 365-82. doi: 10.1007/978-1-59745-177-2_19.

Yuriev E, Ramsland PA. Latest developments in molecular docking: 2010-2011 in review. J Mol Recognit. 2013 May;26(5):215-39. doi: 10.1002/jmr.2266, PMID 23526775.

Dallakyan Sargis, Olson AJ. Small-molecule library screening by docking with PyRX. Methods Mol Biol. 2015;1263:243-50. doi: 10.1007/978-1-4939-2269-7_19, PMID 25618350.

Bhowmik R, Roy S, Sengupta S, Sharma S. Biocomputational and pharmacological analysis of phytochemicals from Zingiber officinale (Ginger), allium sativum (garlic), and murrayakoenigii (curry leaf) in contrast to type 2-diabetes. Int J App Pharm. 2021;13(5):280-6. doi: 10.22159/ijap.2021v13i5.42294.

Korassa YB, Saptarini NM, Mustarichie R, Hendriani R, Tjitda PJ. In silico study of 12 phytosterol compounds in Moringa (Moringa oleifera lam.) seed oil on 5α-reductase enzyme inhibition activity as anti-alopecia. International Journal of Applied Pharmaceutics. 2022;14(4):49-57. doi: 10.22159/ijap.2022.v14s4.OP11

Grafone T, Palmisano M, Nicci C, Storti S. An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment. Oncol Rev. 2012 Mar 3;6(1):e8. doi: 10.4081/oncol.2012.e8, PMID 25992210.

Kumari A, Singh RK. Medicinal chemistry of indole derivatives: current to future therapeutic prospectives. Bioorg Chem. 2019 Aug 1;89:103021. doi: 10.1016/j.bioorg.2019.103021, PMID 31176854.